Inotiv, Inc. to Present at Jefferies Global Healthcare Conference 2025
Inotiv (NASDAQ: NOTV), a contract research organization focused on nonclinical and analytical drug discovery and development services, has announced its participation in the upcoming Jefferies Global Healthcare Conference in New York. Robert Leasure Jr., President and CEO, will deliver a presentation on June 4 at 3:45 p.m. ET. The presentation will be available via live webcast through the company's investor relations website section and will remain accessible for approximately 90 days after the event.
Inotiv (NASDAQ: NOTV), un'organizzazione di ricerca a contratto specializzata in servizi non clinici e analitici per la scoperta e lo sviluppo di farmaci, ha annunciato la sua partecipazione alla prossima Jefferies Global Healthcare Conference a New York. Robert Leasure Jr., Presidente e CEO, terrà una presentazione il 4 giugno alle 15:45 ET. La presentazione sarà disponibile in diretta streaming attraverso la sezione investor relations del sito web aziendale e resterà accessibile per circa 90 giorni dopo l'evento.
Inotiv (NASDAQ: NOTV), una organización de investigación por contrato centrada en servicios no clínicos y analíticos para el descubrimiento y desarrollo de fármacos, ha anunciado su participación en la próxima Jefferies Global Healthcare Conference en Nueva York. Robert Leasure Jr., presidente y CEO, ofrecerá una presentación el 4 de junio a las 3:45 p.m. ET. La presentación estará disponible en transmisión en vivo a través de la sección de relaciones con inversores del sitio web de la empresa y permanecerá accesible durante aproximadamente 90 días después del evento.
Inotiv (NASDAQ: NOTV)는 비임상 및 분석적 신약 발견과 개발 서비스를 전문으로 하는 계약 연구 기관으로, 뉴욕에서 열리는 Jefferies Global Healthcare Conference에 참가한다고 발표했습니다. Robert Leasure Jr. 사장 겸 CEO가 6월 4일 오후 3시 45분(동부시간)에 발표를 진행할 예정입니다. 발표는 회사 투자자 관계 웹사이트를 통해 생중계되며, 행사 후 약 90일간 다시 시청할 수 있습니다.
Inotiv (NASDAQ : NOTV), une organisation de recherche sous contrat spécialisée dans les services non cliniques et analytiques pour la découverte et le développement de médicaments, a annoncé sa participation à la prochaine Jefferies Global Healthcare Conference à New York. Robert Leasure Jr., président et PDG, fera une présentation le 4 juin à 15h45 (heure de l'Est). La présentation sera accessible en direct via la section relations investisseurs du site web de la société et restera disponible pendant environ 90 jours après l'événement.
Inotiv (NASDAQ: NOTV), ein auf nichtklinische und analytische Dienstleistungen für die Wirkstoffforschung und -entwicklung spezialisiertes Vertragsforschungsunternehmen, hat seine Teilnahme an der bevorstehenden Jefferies Global Healthcare Conference in New York angekündigt. Robert Leasure Jr., Präsident und CEO, wird am 4. Juni um 15:45 Uhr ET eine Präsentation halten. Die Präsentation wird live über den Bereich Investor Relations auf der Unternehmenswebsite übertragen und etwa 90 Tage nach der Veranstaltung verfügbar bleiben.
- None.
- None.
WEST LAFAYETTE, Ind., May 22, 2025 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company” or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research models and related products and services, today announced that Robert Leasure Jr., President and Chief Executive Officer will present at the upcoming Jefferies Global Healthcare Conference in New York. The live presentation will take place on Wednesday, June 4 at 3:45 p.m. ET.
The live webcast can be accessed in the “Investors” section of Inotiv’s website and will be archived for approximately 90 days following the event.
About the Company
Inotiv, Inc. is a leading contract research organization dedicated to providing nonclinical and analytical drug discovery and development services and research models and related products and services. The Company’s products and services focus on bringing new drugs and medical devices through the discovery and preclinical phases of development, all while increasing efficiency, improving data, and reducing the cost of taking new drugs and medical devices to market. Inotiv is committed to supporting discovery and development objectives as well as helping researchers realize the full potential of their critical research and development projects, all while working together to build a healthier and safer world. Further information about Inotiv can be found here: https://www.inotiv.com/.
This release may contain forward-looking statements that are subject to risks and uncertainties including, but not limited to, risks and uncertainties related to the impact of recent events related to non-human primate matters on the Company’s business, operations, results, financial condition, cash flows, and assets, the Company’s ability to comply with covenants under its credit agreement, compliance with the Resolution and Plea Agreements with the DOJ and the expected impacts on the Company related to the compliance plan, compliance monitor, and the expected financial commitments, changes in the market and demand for the Company’s products and services, the development, marketing and sales of products and services, changes in technology, industry and regulatory standards, the timing of acquisitions and the successful closing, integration and business and financial impact thereof, governmental regulations, inspections and investigations, claims and litigation against or involving the Company, its business and/or its industry, the impact of site closures and consolidations, expansion and related efforts, and various other market and operating risks, including those detailed in the Company's filings with the U.S. Securities and Exchange Commission.
| Company Contact | Investor Relations |
| Inotiv, Inc. | LifeSci Advisors |
| Beth A. Taylor, Chief Financial Officer | Steve Halper |
| (765) 497-8381 | (646) 876-6455 |
| beth.taylor@inotiv.com | shalper@lifesciadvisors.com |
FAQ
When is Inotiv (NOTV) presenting at the Jefferies Global Healthcare Conference 2025?
How can I watch Inotiv's (NOTV) presentation at the Jefferies Healthcare Conference?
Who is presenting for Inotiv (NOTV) at the Jefferies Global Healthcare Conference 2025?
What services does Inotiv (NOTV) provide as a company?
